A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

A New Tool Is Added to the COVID-19 Armamentarium


The United States Food and Drug Administration has given the green light to a pill, made by Pfizer, designed to treat COVID-19.  The oral antiviral medication is the first of its kind to gain approval for the treatment of SARS-CoV-2 infection. A clinical study conducted by Pfizer demonstrated that the medication, called Paxlovid, was effective at decreasing the risk of hospitalization as well as death among those most vulnerable to severe COVID-19 illness. The medication regimen must begin within 3 days of symptoms emerging, and is taken twice per day for 5 days. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy